The U.S. Food and Drug Administration (FDA) warns two companies for selling unlawful products labeled containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the warning letters address the illegal...
Have routine FDA inspections resumed in any capacity? If not, what can industry members expect in 2021 amidst COVID-19? At the onset of the COVID-19 pandemic in 2020, FDA announced a temporary halt to on-site facility inspections. With few exceptions, the agency made...
If you search Sephora’s online catalogue for CBD and you’ll be directed to a selection of approximately 32 skincare products, 14 bath and body items, four fragrances, and two haircare SKUs. That’s quite a selection, and the international beauty emporium wouldn’t have...
From a prominent dietary supplement company to an advocacy group for the pharmacy profession and coalition fighting obesity, various stakeholders of the Dietary Supplement Quality Collaborative support and push for an FDA proposal for a mandatory product listing....
The US Food and Drug Administration (FDA) has finalized its guidance to generic drug manufacturers on how to seek drug development information through the controlled correspondence process. The guidance incorporates changes that were part of the reauthorization of the...